ID   PACN1_RAT               Reviewed;         441 AA.
AC   Q9Z0W5;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   24-JAN-2024, entry version 155.
DE   RecName: Full=Protein kinase C and casein kinase substrate in neurons protein 1;
DE   AltName: Full=Dynamin proline-rich domain-interacting protein;
DE            Short=Dynamin PRD-interacting protein;
DE   AltName: Full=Synaptic, dynamin-associated protein I;
DE   AltName: Full=Syndapin-1;
DE   AltName: Full=Syndapin-I;
DE            Short=SdpI;
GN   Name=Pacsin1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 71-90 AND 412-429,
RP   INTERACTION WITH DNM1; SYNJ1 AND WASL, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF PRO-434.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9950691; DOI=10.1091/mbc.10.2.501;
RA   Qualmann B., Roos J., DiGregorio P.J., Kelly R.B.;
RT   "Syndapin I, a synaptic dynamin-binding protein that associates with the
RT   neural Wiskott-Aldrich syndrome protein.";
RL   Mol. Biol. Cell 10:501-513(1999).
RN   [2]
RP   PROTEIN SEQUENCE OF 71-79; 197-215; 252-266; 274-282 AND 389-404, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Diao W., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11082044; DOI=10.1242/jcs.113.24.4511;
RA   Modregger J., Ritter B., Witter B., Paulsson M., Plomann M.;
RT   "All three PACSIN isoforms bind to endocytic proteins and inhibit
RT   endocytosis.";
RL   J. Cell Sci. 113:4511-4521(2000).
RN   [4]
RP   INTERACTION WITH EHD1 AND EHD3, AND TISSUE SPECIFICITY.
RX   PubMed=15930129; DOI=10.1091/mbc.e05-01-0076;
RA   Braun A., Pinyol R., Dahlhaus R., Koch D., Fonarev P., Grant B.D.,
RA   Kessels M.M., Qualmann B.;
RT   "EHD proteins associate with syndapin I and II and such interactions play a
RT   crucial role in endosomal recycling.";
RL   Mol. Biol. Cell 16:3642-3658(2005).
RN   [5]
RP   FUNCTION, INTERACTION WITH DNM1, PARTIAL PROTEIN SEQUENCE, SUBCELLULAR
RP   LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16648848; DOI=10.1038/nn1695;
RA   Anggono V., Smillie K.J., Graham M.E., Valova V.A., Cousin M.A.,
RA   Robinson P.J.;
RT   "Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic
RT   vesicle endocytosis.";
RL   Nat. Neurosci. 9:752-760(2006).
RN   [6]
RP   INTERACTION WITH COBL AND DBNL.
RX   PubMed=17956734; DOI=10.1016/j.cell.2007.08.030;
RA   Ahuja R., Pinyol R., Reichenbach N., Custer L., Klingensmith J.,
RA   Kessels M.M., Qualmann B.;
RT   "Cordon-bleu is an actin nucleation factor and controls neuronal
RT   morphology.";
RL   Cell 131:337-350(2007).
RN   [7]
RP   FUNCTION, INTERACTION WITH DNM1, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=17437541; DOI=10.1111/j.1471-4159.2007.04574.x;
RA   Anggono V., Robinson P.J.;
RT   "Syndapin I and endophilin I bind overlapping proline-rich regions of
RT   dynamin I: role in synaptic vesicle endocytosis.";
RL   J. Neurochem. 102:931-943(2007).
RN   [8]
RP   FUNCTION, DOMAIN, SUBCELLULAR LOCATION, AND INTERACTION WITH WASL.
RX   PubMed=19846719; DOI=10.1523/jneurosci.3973-09.2009;
RA   Dharmalingam E., Haeckel A., Pinyol R., Schwintzer L., Koch D.,
RA   Kessels M.M., Qualmann B.;
RT   "F-BAR proteins of the syndapin family shape the plasma membrane and are
RT   crucial for neuromorphogenesis.";
RL   J. Neurosci. 29:13315-13327(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH COBL, AND IDENTIFICATION
RP   IN A COMPLEX WITH COBL AND WASL.
RX   PubMed=21725280; DOI=10.1038/emboj.2011.207;
RA   Schwintzer L., Koch N., Ahuja R., Grimm J., Kessels M.M., Qualmann B.;
RT   "The functions of the actin nucleator Cobl in cellular morphogenesis
RT   critically depend on syndapin I.";
RL   EMBO J. 30:3147-3159(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-346; SER-358; SER-362
RP   AND SER-427, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [11]
RP   FUNCTION, PHOSPHORYLATION AT SER-76 AND THR-181, IDENTIFICATION BY MASS
RP   SPECTROMETRY, SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH DNM1 AND
RP   WASL, DOMAIN, MUTAGENESIS OF 62-LYS-LYS-63; SER-76; LYS-127; LYS-130;
RP   154-LYS-LYS-155; THR-181; ASP-276 AND ASP-280, AND TISSUE SPECIFICITY.
RX   PubMed=22355135; DOI=10.1073/pnas.1108294109;
RA   Quan A., Xue J., Wielens J., Smillie K.J., Anggono V., Parker M.W.,
RA   Cousin M.A., Graham M.E., Robinson P.J.;
RT   "Phosphorylation of syndapin I F-BAR domain at two helix-capping motifs
RT   regulates membrane tubulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:3760-3765(2012).
CC   -!- FUNCTION: Binds to membranes via its F-BAR domain and mediates membrane
CC       tubulation. Plays a role in the reorganization of the microtubule
CC       cytoskeleton via its interaction with MAPT; this decreases microtubule
CC       stability and inhibits MAPT-induced microtubule polymerization. Plays a
CC       role in cellular transport processes by recruiting DNM1, DNM2 and DNM3
CC       to membranes. Plays a role in the reorganization of the actin
CC       cytoskeleton and in neuron morphogenesis via its interaction with COBL
CC       and WASL, and by recruiting COBL to the cell cortex. Plays a role in
CC       the regulation of neurite formation, neurite branching and the
CC       regulation of neurite length. Required for normal synaptic vesicle
CC       endocytosis; this process retrieves previously released
CC       neurotransmitters to accommodate multiple cycles of neurotransmission.
CC       Required for normal excitatory and inhibitory synaptic transmission.
CC       {ECO:0000269|PubMed:16648848, ECO:0000269|PubMed:17437541,
CC       ECO:0000269|PubMed:19846719, ECO:0000269|PubMed:21725280,
CC       ECO:0000269|PubMed:22355135}.
CC   -!- SUBUNIT: Homodimer. May form heterooligomers with other PACSINs.
CC       Interacts with MAPT. Interacts with TRPV4 (By similarity). Interacts
CC       (via SH3 domain) with SYNJ1 and WASL. Interacts (via SH3 domain) with
CC       DNM1; the interaction is reduced by DNM1 phosphorylation. Interacts
CC       with DNM2 and DNM3. Interacts with both COBL and DBNL. Identified in a
CC       complex composed of COBL, PACSIN1 and WASL. Interacts with EHD1 and
CC       EHD3. {ECO:0000250, ECO:0000269|PubMed:15930129,
CC       ECO:0000269|PubMed:16648848, ECO:0000269|PubMed:17437541,
CC       ECO:0000269|PubMed:17956734, ECO:0000269|PubMed:19846719,
CC       ECO:0000269|PubMed:21725280, ECO:0000269|PubMed:22355135,
CC       ECO:0000269|PubMed:9950691}.
CC   -!- INTERACTION:
CC       Q9Z0W5; D3ZUI5: Cobl; NbExp=6; IntAct=EBI-1550185, EBI-7003590;
CC       Q9Z0W5; P21575: Dnm1; NbExp=4; IntAct=EBI-1550185, EBI-80070;
CC       Q9Z0W5; Q5NBX1: Cobl; Xeno; NbExp=14; IntAct=EBI-1550185, EBI-1550138;
CC       Q9Z0W5; Q5NBX1-1: Cobl; Xeno; NbExp=2; IntAct=EBI-1550185, EBI-16174243;
CC       Q9Z0W5; Q9NZQ3: NCKIPSD; Xeno; NbExp=6; IntAct=EBI-1550185, EBI-745080;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell projection. Synapse, synaptosome.
CC       Cell projection, ruffle membrane {ECO:0000250}. Membrane; Peripheral
CC       membrane protein. Cytoplasmic vesicle membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Synapse {ECO:0000250}.
CC       Cytoplasm, cytosol {ECO:0000250}. Cell membrane; Peripheral membrane
CC       protein; Cytoplasmic side. Note=Colocalizes with MAPT in axons (By
CC       similarity). In primary neuronal cultures, present at a high level in
CC       presynaptic nerve terminals and in the cell body. Colocalizes with DNM1
CC       at vesicular structures in the cell body and neurites. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain (at protein level).
CC       {ECO:0000269|PubMed:15930129, ECO:0000269|PubMed:17437541,
CC       ECO:0000269|PubMed:22355135, ECO:0000269|PubMed:9950691}.
CC   -!- DOMAIN: The F-BAR domain forms a coiled coil and mediates membrane-
CC       binding and membrane tubulation. In the autoinhibited conformation,
CC       interaction with the SH3 domain inhibits membrane tubulation mediated
CC       by the F-BAR domain. DNM1 binding abolishes autoinhibition (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated by casein kinase 2 (CK2) and protein kinase C
CC       (PKC). {ECO:0000305|PubMed:22355135}.
CC   -!- SIMILARITY: Belongs to the PACSIN family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF104402; AAD16887.1; -; mRNA.
DR   RefSeq; NP_058990.1; NM_017294.1.
DR   AlphaFoldDB; Q9Z0W5; -.
DR   SMR; Q9Z0W5; -.
DR   BioGRID; 248321; 4.
DR   DIP; DIP-39836N; -.
DR   ELM; Q9Z0W5; -.
DR   IntAct; Q9Z0W5; 8.
DR   MINT; Q9Z0W5; -.
DR   STRING; 10116.ENSRNOP00000069980; -.
DR   GlyGen; Q9Z0W5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Z0W5; -.
DR   PhosphoSitePlus; Q9Z0W5; -.
DR   SwissPalm; Q9Z0W5; -.
DR   PaxDb; 10116-ENSRNOP00000036285; -.
DR   Ensembl; ENSRNOT00065042381; ENSRNOP00065034675; ENSRNOG00065024677.
DR   GeneID; 29704; -.
DR   KEGG; rno:29704; -.
DR   UCSC; RGD:3247; rat.
DR   AGR; RGD:3247; -.
DR   CTD; 29993; -.
DR   RGD; 3247; Pacsin1.
DR   eggNOG; KOG2856; Eukaryota.
DR   InParanoid; Q9Z0W5; -.
DR   OrthoDB; 9421at2759; -.
DR   PhylomeDB; Q9Z0W5; -.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:Q9Z0W5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043679; C:axon terminus; IDA:UniProtKB.
DR   GO; GO:0030137; C:COPI-coated vesicle; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0098684; C:photoreceptor ribbon synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0098833; C:presynaptic endocytic zone; ISO:RGD.
DR   GO; GO:0032587; C:ruffle membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:BHF-UCL.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0007015; P:actin filament organization; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; IDA:RGD.
DR   GO; GO:0045806; P:negative regulation of endocytosis; ISO:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:UniProtKB.
DR   GO; GO:0097320; P:plasma membrane tubulation; IMP:UniProtKB.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IDA:BHF-UCL.
DR   GO; GO:0072657; P:protein localization to membrane; ISS:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030100; P:regulation of endocytosis; IBA:GO_Central.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; IDA:SynGO.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB.
DR   CDD; cd07680; F-BAR_PACSIN1; 1.
DR   CDD; cd11998; SH3_PACSIN1-2; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR035743; PACSIN1/PACSIN2_SH3.
DR   InterPro; IPR037454; PACSIN1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR23065; PROLINE-SERINE-THREONINE PHOSPHATASE INTERACTING PROTEIN 1; 1.
DR   PANTHER; PTHR23065:SF16; PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS PROTEIN 1; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Endocytosis; Lipid-binding;
KW   Membrane; Phosphoprotein; Reference proteome; SH3 domain; Synapse;
KW   Synaptosome.
FT   CHAIN           1..441
FT                   /note="Protein kinase C and casein kinase substrate in
FT                   neurons protein 1"
FT                   /id="PRO_0000161794"
FT   DOMAIN          10..280
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          382..441
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          310..380
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          23..272
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        328..352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61644"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61644"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         391
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61644"
FT   MOD_RES         402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61644"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         62..63
FT                   /note="KR->QQ: Reduces membrane-binding. Abolishes membrane
FT                   tubulation."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         76
FT                   /note="S->A: No effect on membrane-binding. Reduces
FT                   membrane tubulation."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         127
FT                   /note="K->Q: Reduces membrane-binding; when associated with
FT                   Q-130. Abolishes membrane tubulation."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         130
FT                   /note="K->Q: Reduces membrane-binding. Abolishes membrane
FT                   tubulation; when associated with Q-127."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         154..155
FT                   /note="KK->QQ: Reduces membrane-binding. Abolishes membrane
FT                   tubulation."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         181
FT                   /note="T->A: No effect on membrane-binding."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         181
FT                   /note="T->E: Reduces membrane-binding. Abolishes membrane
FT                   tubulation."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         276
FT                   /note="D->A: Reduces membrane tubulation; when associated
FT                   with A-280."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         280
FT                   /note="D->A: Reduces membrane tubulation; when associated
FT                   with A-276."
FT                   /evidence="ECO:0000269|PubMed:22355135"
FT   MUTAGEN         434
FT                   /note="P->L: Abolishes interaction with DNM1, SYNJ1 and
FT                   WASL."
FT                   /evidence="ECO:0000269|PubMed:9950691"
SQ   SEQUENCE   441 AA;  50449 MW;  585B328850572DF8 CRC64;
     MSGPYDEASE EITDSFWEVG NYKRTVKRID DGHRLCNDLM SCVQERAKIE KAYAQQLTDW
     AKRWRQLIEK GPQYGSLERA WGAMMTEADK VSELHQEVKN SLLNEDLEKV KNWQKDAYHK
     QIMGGFKETK EAEDGFRKAQ KPWAKKMKEL EAAKKAYHLA CKEEKLAMTR EMNSKTEQSV
     TPEQQKKLVD KVDKCRQDVQ KTQEKYEKVL EDVGKTTPQY MEGMEQVFEQ CQQFEEKRLV
     FLKEVLLDIK RHLNLAENSS YIHVYRELEQ AIRGADAQED LRWFRSTSGP GMPMNWPQFE
     EWNPDLPHTA AKKEKQPKKA EGAALSNATG AVESTSQAGD RGSVSSYDRG QAYATEWSDD
     ESGNPFGGNE ANGGANPFED DAKGVRVRAL YDYDGQEQDE LSFKAGDELT KLGEEDEQGW
     CRGRLDSGQL GLYPANYVEA I
//
